These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10694571)

  • 1. BRCA1/2 germline mutations: a marker for radioresistance or radiosensitivity?
    Formenti SC; Preston-Martin S; Haffty BG
    J Clin Oncol; 2000 Mar; 18(5):1159-60. PubMed ID: 10694571
    [No Abstract]   [Full Text] [Related]  

  • 2. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.
    Ramus SJ; Friedman LS; Gayther SA; Ponder BA; Bobrow L; van der Looji M; Papp J; Olah E
    Nat Genet; 1997 Jan; 15(1):14-5. PubMed ID: 8988162
    [No Abstract]   [Full Text] [Related]  

  • 3. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
    van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
    Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.
    De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA
    Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A breast cancer patient of Scottish descent with germ-line mutations in BRCA1 and BRCA2.
    Liede A; Rehal P; Vesprini D; Jack E; Abrahamson J; Narod SA
    Am J Hum Genet; 1998 Jun; 62(6):1543-4. PubMed ID: 9585617
    [No Abstract]   [Full Text] [Related]  

  • 6. Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2.
    Foray N; Randrianarison V; Marot D; Perricaudet M; Lenoir G; Feunteun J
    Oncogene; 1999 Dec; 18(51):7334-42. PubMed ID: 10602489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [BRCA1 and BRCA2--breast cancer susceptibility genes].
    Dagan E; Gershoni-Baruch R
    Harefuah; 1997 Nov; 133(10):455-7. PubMed ID: 9418320
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriers.
    Staff S; Nupponen NN; Borg A; Isola JJ; Tanner MM
    Genes Chromosomes Cancer; 2000 Aug; 28(4):432-42. PubMed ID: 10862052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes.
    Eisinger F; Jacquemier J; Noguès C; Birnbaum D; Sobol H
    Cancer; 1999 May; 85(10):2291-5. PubMed ID: 10326710
    [No Abstract]   [Full Text] [Related]  

  • 10. Are local recurrences after breast conserving therapy more frequent in patients with BRCA1/BRCA2 mutations?
    Kurtz JM
    Strahlenther Onkol; 2000 Sep; 176(9):433-4. PubMed ID: 11050918
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinicopathological characteristics of hereditary breast cancer].
    Ikeda N; Miyoshi Y; Noguchi S
    Nihon Rinsho; 2000 Apr; 58 Suppl():533-6. PubMed ID: 11026045
    [No Abstract]   [Full Text] [Related]  

  • 12. [Genetic diagnosis of hereditary breast cancer].
    Yano K; Miki Y
    Nihon Rinsho; 2000 Apr; 58 Suppl():527-32. PubMed ID: 11026044
    [No Abstract]   [Full Text] [Related]  

  • 13. Search for TSG101 germ-line mutations in BRCA1/BRCA2-negative breast/ovarian cancer families.
    Hofferbert S; Brohm M; Weber BH
    Cancer Genet Cytogenet; 1998 Apr; 102(1):86-7. PubMed ID: 9530348
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pregnancy and risk of early breast cancer in patients sith BRCA1 and BRCA2 mutations].
    Ost E; Illiger HJ
    Strahlenther Onkol; 2000 Jul; 176(7):335-6. PubMed ID: 10963002
    [No Abstract]   [Full Text] [Related]  

  • 15. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
    Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women.
    Noguchi S; Kasugai T; Miki Y; Fukutomi T; Emi M; Nomizu T
    Cancer; 1999 May; 85(10):2200-5. PubMed ID: 10326698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
    Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
    Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.
    Armes JE; Trute L; White D; Southey MC; Hammet F; Tesoriero A; Hutchins AM; Dite GS; McCredie MR; Giles GG; Hopper JL; Venter DJ
    Cancer Res; 1999 Apr; 59(8):2011-7. PubMed ID: 10213514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of familial breast cancers].
    Nomizu T; Ito K
    Nihon Rinsho; 2000 Apr; 58 Suppl():537-41. PubMed ID: 11026046
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations.
    Khoo US; Ngan HY; Cheung AN; Chan KY; Lu J; Chan VW; Lau S; Andrulis IL; Ozcelik H
    Hum Mutat; 2000 Jul; 16(1):88-9. PubMed ID: 10874312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.